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We have shown, in the previous publication, that when SJL/J (Ig  b) male mice are 
mated to BALB/c (Ig  a) females immunized against the Ig-lb (3'G2a) allotype, many 
of the resultant F1 heterozygous (Iga/Ig  b) progeny are chronically suppressed for Ig- 
lb production. That is, many of the progeny are either unable to produce detectable 
amounts of circulating Ig-lb or, having produced it, are unable to sustain production, 
so that by about 6 months of age they have become phenotypically negative for the 
paternal allele. Since repopulation of irradiated (600  R)  chronically suppressed mice 
with spleen cells from nonsuppressed mice did not restore Ig-lb production, we con- 
clude that chronic suppression was  due  to  an active process, relatively resistant to 
irradiation, which prevents expression of the paternal (Ig-lb) allele (1). 
In this publication we describe the results obtained when cells from chroni- 
cally suppressed mice  are  transferred,  either  alone  or  together  with  normal, 
syngeneic spleen cells, into irradiated hosts of another allotype. These results 
confirm the concept  of an active suppressing mechanism and strongly suggest 
that it is manifested by cells resident in the lymphoid tissue of the suppressed 
mice.  A  discussion  of  possible mechanisms  of  active  allotype  suppression  is 
presented. 
Materials and Methods 
The materials and methods used in this study are identical with those used in the previous 
publication (1) with the following exceptions: 
Mice.--In  addition to the strains described in the previous publication, BAB/14, a strain 
congenic with BALB/c (Ig  a) but carrying the Ig  b alleles, was used in the work reported here. 
Mixture of Suppressed and Normal Cells before Transfer.--Cell suspensions,  prepared as 
described (1), were mixed and stored on ice for no more than 30 rain before injection into recip- 
ients. 
Anti-Sheep Erythroeyte Plaque Formation.--Normal (nonsuppressed)  (SJL X  BALB/c)F1 
* Supported by National Institutes of Health grant Nos. AI 08917-07, HD 01287-08, and 
CA 04681-07. 
:~ Present address: Basel Institute for Immunology, Basel, Switzerland. 
THE JOURNAL OF EXPERIMENTAL MEDICINE • VOLUME 135,  1972  1163 1164  SUPPRESSION  OF IMMUNOGLOBULIN ALLOTYPE  SYNTHESIS.  II 
recipients were  injected intravenously (i.v.), 1 4-6 hr after  irradiation, with  primed  spleen 
cells from chronically suppressed mice immunized 8-105 days previously. Control mice were 
injected with primed cells from nonsuppressed donors. A challenge dose  of 4  X  l0  s  sheep 
erythrocytes (SRBC) was injected simultaneously. The recipients were sacrificed 7 days after 
transfer and their spleen cells assayed  for TCn.a plaque-forming cells  (PFC)  as previously 
described (2). 
TABLE  I 
Ig-lb  Production in Irradiated BALB/c  (Iga/Ig a)  Recipients of Pooled Cells from  Normal 
or Suppressed Donors 
cells*  (SJL X  BALB/c) FI  Experi- 
Don(.so  .or  of cells transferred  ment No. 
per recipient) 
No. positive for Ig-lb/totals 
(weeks after transfer)] 
Mean level§ in pos 
itive mice at week 7 
2  3  5  7  Ig lb  Ig-4b 
mg/ml  mg/ml 
Suppressed  spleen (1.4 X  107)  3  5/10  5/9  1/9  0/9  --  0.91 
7  4/6  4/5  0/5  0/5  --  1.9 
4  10/10  8/9  7/9  4/9  0.5  1.2 
Total  19/26  17/23  8/23  4/23 
Normal spleen (1.4 X  107)  3  2/2  2/2  2/2  2/2  1.47  t. 5 
7  1/1  1/1  1/1  1/1  2.1  0.4 
Total  3/3  3/3  3/3  3/3 
Suppressed bone marrow  3  5/6  4/5  1/5  0/5  --  1.3 
(5 X  10 6)  7  4/8  3/7  4/7  4/7  0.8  0.4 
4  1/6  5/6  5/6  4/5  1.4  1.1 
Total  10/20  12/18  10/18  8/17 
Normal bone marrow  3  2/2  2,/2  2/2  2/2  1.7  0.72 
(5  X  106)  7  2/2  2/2  2/2  2/2  0.9  1.8 
Total  4/4  4/4  4/4  4/4 
* Suppressed spleen and bone marrow were pooled cell suspensions from three mice. Nor- 
real and spleen cells were obtained from individual animals. Recipients were irradiated with 
600 R total body irradiation approximately 18 hr before transfer, 
* Tested by double diffusion in agar. By the same method, all of the mice were positive 
for Ig-la. 
§ As determined by the method of inhibition of 125I precipitation described in reference  1. 
For Ig-lb,  negative mice had less than 0.025 mg/ml; for Ig-4b, all mice were positive. 
RESULTS 
Suppression  of  Ig-lb  Synthesis  in  Transferred  Populations  of  Suppressed 
Cells.--Spleen  cells  or  bone marrow  (B)  cells from  chronically suppressed  or 
normal mice were  injected i.v. into irradiated  BALB/c  (non-Ig  b)  recipients. 
The serum levels of Ig-lb in these recipients were determined at weekly inter- 
vals by means of imlnunodiffusion in agar. 
1 Abbreviations used in this paper: B, bone marrow; i.p., intraperitoneally; i.v., intraven- 
ously; PFC, plaque-forming cells; SRBC, sheep erythrocytes. JACOBSON, I-IERZENBERG,  RIBLET,  AND tIERZENBERG  1165 
Tables I  and II show that,  while a  majority of the recipients injected with 
spleen cells from  suppressed donors had  detectable levels of circulating Ig-lb 
early after transfer, these levels decreased with time until no longer detectable. 
Although a few of the mice were still positive for Ig-lb at week 7, the individual 
test records (not presented) show a pattern of fluctuation of Ig-lb levels similar 
to that seen in untreated suppressed mice. 
TABLE II 
Ig-lb Production in BALB/c Mice Injected with Suppressed or Normal Spleen Cells from 
Individual  Donors 
Donor cells 
(SJL X  BALB/c)FI*  Donor No. 
No. positive for Ig-lb/total$ 
(weeks  after transfer) 
Mean level in positive 
mice on week 7 
1  3  5  7  Ig-lb§  Ig-4b 
Suppressed spleen 
mg /ml  mg /ml 
1  3/4  3/3  0/3  1/3  0.17  1.2 
2  1/4  2/4  2/4  1/4  0.11  0.85 
3  1/4  1/4  1/4  0/4  --  0.5 
4  4/4  3/4  0/4  0/4  --  0.8 
5  0/4  0/4  0/4  1/4  0.056  0.6 
6  4/4  3/4  0/4  0/4  --  0.5 
7  3/4  2/4  3/4  1/2  0.11  1.0 
8  3/3  3/3  0/3  0/3  --  0.6 
9  3/3  3/3  1/3  1/3  0.42  0.6 
10  3/3  3/3  2/3  2/3  0.42  1.0 
11  3/3  2/2  1/2  1/2  0.8  1.1 
Total  28/40  25/38  10/38  8/36 
Normal spleen  12  4/4  4/4  4/4  4/4  0.85  0.44 
13  4/4  4/4  4/4  4/4  0.75  0.6 
14  3/3  3/3  3/3  3/3  0.75  0.4 
15  3/3  3/3  2/2  2/2  0.4  1.0 
Total  14/14  14/14  13/13  13/13 
* 1.2-1.5 X  l0  T  spleen cells from individual mice were injected i.v. into groups of BALB/c 
mice irradiated with 600 R 18 hr previously. 
Ig-lb tested by double diffusion in agar. 
§ Arithmetic mean of positives only. All mice were positive for Ig-4b. Determined by in- 
hibition of 125I precipitation. 
Transferred  B  cells from  suppressed  mice  showed  a  stronger  tendency  to 
sustain  Ig-lb  production  after  transfer,  although  many  of  the  recipients  of 
these cells did become suppressed by week 7 (Table I). 
Since the recipients of suppressed cells continued to produce Ig-4b, another 
immunoglobulin class (3'G1) carrying the paternal allotype, the disappearance 
of Ig-lb from the sera of these recipients was clearly not due to rejection of the 
transferred cells. In addition, it can be seen in the tables that cells transferred 
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removal of cells from the suppressed host environment and their expansion in a 
neutral recipient does not allow more than a minimal restoration of Ig-lb pro- 
duction. 
Since suppression has been shown to be physiologically dominant,  i.e.  is  an 
active process whereby a  known competent cell population is rendered incom- 
TABLE III 
Ig-Ib Production in BA B/14 (Ig  b) Recipients of Normal and Suppressed Cells 
Donor cells*  (SJL X  BALB/c)Fl  Experiment 
(No. of cells transferred  per recipient)  No. 
No. positive for Ig-lb/total,  + 
(weeks after transfer) 
2  3  5  7 
Suppressed  spleen (1.4 X  107) 
Normal spleen  (1.4 X  10  7) 
Suppressed bone marrow (5 X  106) 
Normal bone marrow (5 X  106) 
3  10/10  10/10  1/10§  1/10 
7  2/2  2/2  2/2  1/1 
4  5/5  5/5  4/5  3/511 
Total  17/17  17/17  7/17  5/16 
3  2/2  2/2  2/2  2/2 
7  1/1  1/1  1/1  1/1 
Total  3/3  3/3  3/3  3/3 
3  6/6  6/6  6/6  6/6 
7  2/2  2/2  2/2  2/2 
4  6/6  5/5  5/5  5/5 
Total  14/14  13/13  13/13  13/13 
3  2/2  1/1  1/1  1/1 
7  1/1  1/1  1/1  1/t 
Total  3/3  2/2  2/2  2/2 
* The suppressed spleen and B cell suspensions used in each experiment were pooled from 
three mice. Normal B and spleen cells were obtained from individual animals. Recipients were 
irradiated (600 R) approximately 18 hr before transfer. 
Ig-lb tested by double diffusion in agar. By the same method, all of the mice were posi- 
tive for Ig-la, with the exception of the two positive mice in experiments 3 and 7. These mice 
were negative for Ig-la by week 7. 
§ Low levels of Ig-Ib were still detectable in the sera of five of the mice at week 4 (not 
shown in table). 
/I The level of Ig-lb detected in these three mice was very low. 
petent  (1),  the demonstration of initial Ig-lb production and subsequent sup- 
pression  in  transferred  suppressed  cell  populations  suggests  that  the  active 
suppressing factor is transferred  to  the new  host along with  cells capable of 
giving rise to Ig-lb production. Further support for this contention comes from 
data  on  transfers  of  suppressed  and  nonsuppressed  cell populations  into  Ig  b 
hornozygous hosts (BAB/14)  congenic with BALB/c. These experiments were 
performed originally as transplantation controls to show persistence of the F1 
(Ig~/Ig  b)  cells in irradiated  parents.  As  executed,  using  production  of  Ig-la JACOBSON, HERZENBERG, RIBLET, AND HERZENBERG  1167 
as  a  marker,  F1  spleen  or  B  cells  of  either suppressed or normal origin per- 
sisted equally well. Surprisingly,  it became evident around 5  wk after transfer 
that  many  of  the  irradiated  Ig  ~ homozygous  recipients  of suppressed  spleen 
cells had lost their ability to produce Ig-lb (see Table III). 
There  appear  to be  only  two  possible  explanations  for  these  totally  unex- 
pected results: (a) that the suppressing factor is powerful enough to completely 
repress the recipients' endogenous production  of Ig-lb, or (b)  that overgrowth 
of the  injected  cell population  has  occurred  and  the  recipients  have  been  re- 
TABLE  IV 
Failure of High Levels of Ig-lb to Prevent Suppression in BA LB/c Recipients of Suppressed Cells 
Injected  Donor cells  (No. of ceils  No.  positive for Ig-lb~/total  Mean level in 
positive mice at 
serum*  transferred  per recipient)  Before  Weeks after transfer  week 8 
serum 
injection  0  2  4  6  8  Ig-lb§  Ig 4b 
mg /ml  mg /ml 
Ig  b  Suppressed spleen  0/4  4/4  4/4  2/4  1/4  0/3  --  1.6 
(1.5 ×  107) 
Suppressed bone mar-  0/4  4/4  4/4  3/4  4/4  4/4  0.4  0.98 
row (5 ×  10  6) 
Ig  a  Suppressed spleen  0/4  4/4  4/4  1/4  1/4  1/4  0.25  1.2 
(1.5 ×  107) 
Suppressed bone mar-  0/4  4/4  3/3  1/3  3/3  2/3  0.85  1.1 
row (5 X  10  6) 
Ig  b  BALB/c bone mar-  0/4  4/4  4/4  0/4  0/4  0/4 
row (5 ×  10  e) 
* Recipients  were injected with a total of 1.5 ml of BALB/c (Ig  a) or BAB/14 (Ig  b) serum 
before irradiation (600 R) and transfer. 
:~ Determined by immunodiffusion. 
§ Arithmetic mean of positives only. All mice were positive for Ig-4b. Determined by in- 
hibition of a25I precipitation. 
populated by the donor ceils. The latter possibility is most likely, particularly 
in view of the fact that these mice, more than 3 months after transfer, were still 
producing  Ig-la  (and no Ig-lb). Rejection  of the  transferred  cells was seen in 
only 2  of the  16  spleen  cell  recipients,  as evidenced  by the  disappearance  of 
Ig-la from their sera by week 6 or 7 after transfer. Thus, of the five mice posi- 
tive for Ig-lb  at  7  wk,  two had  rejected  the  transferred  cells and  three  were 
producing  only  minimal  amounts  (0.1-0.15  mg/ml).  Since  we  have  clearly 
shown the presence of cells capable of producingIg-lb in these cell inocula (Table 
I), these results verify the concept of a  simultaneously transferred suppressing 
factor, capable of manifesting itself even in an Ig  b homozygous host. 
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the lower efficiency of bone marrow's self-suppression shown in Table I, sug- 
gests that bone marrow has a  smaller or less  effective suppressing population 
than does spleen, although it must be taken into consideration that the number 
of B  cells transferred was always considerably lower than that used in spleen 
cell transfers. 
Suppression of Transferred Populations in Presence of High Levels of Circulat- 
ing Ig-lb.---Although latent production of anti-Ig-lb  or the presence of cell- 
associated cryptic anti-Ig-lb was ruled out earlier as a mechanism for mainte- 
nance of  chronic suppression in intact  animals,  the effect of high  circulating 
levels of Ig-lb  was again investigated, using a  transferred population of sup- 
pressed cells,  to verify this point under more stringent conditions. Before ir- 
radiation  and  transfer,  prospective  BALB/c  recipients  were  injected  with 
normal Ig  b (BAB/14)  serum to create high levels of circulating Ig-lb  at the 
time  of transfer.  A  control group was  injected with Ig  b serum and BALB/c 
normal bone marrow, merely to determine the length of time of detectability 
of the injected serum. The results of this experiment, shown in Table IV, indi- 
cate that the presence of circulating Ig-13 does not prevent suppression of the 
transferred cells,  as was subsequently confirmed by the results obtained with 
BAB/14 mice. 
Suppression of Ig-lb  Synthesis in  Transferred Mixtures of Syngeneic Sup- 
pressed and Normal Cells.--In both this and  the preceding publication (1), we 
have presented experiments in which normal, Ig-lb-producing cell  populations 
were incidentally combined in vivo with suppressed cells and appeared to be- 
come suppressed as a result. Taken as a  whole, these findings strongly suggest 
the existence of an active cell-associated factor which is able to suppress Ig-13 
synthesis in populations of normal cells never exposed to maternal anti-Ig-lb. 
To test this hypothesis more directly,  spleen cells from chronically suppressed 
mice were mixed with spleen cells from normal syngeneic F1 mice in vitro and 
then transferred into irradiated BALB/c (Ig-la) hosts. 
The results of this experinlent are presented in Fig.  1,  where the  average 
Ig-lb levels in the sera of three groups of recipients are plotted as a function of 
time after transfer. These results demonstrate conclusively that ceils from a 
suppressed spleen are able to suppress Ig-lb production by normal spleen cells. 
In the "normal control" group, which received 1.6 X  107 spleen cells from the 
normal F1 donor, the serum level of Ig-lb starts at 0.38 mg/ml, rises to approxi- 
mately 1 mg/ml by the third week,  and then falls to a  stable 0.5 mg/ml by 
week 7. In the  "suppressed control" group, which received 1.2  X  l0 T spleen 
cells from the suppressed donor, the Ig-lb serum level is at 0.1 mg/ml at 1 wk 
after transfer and falls steadily thereafter, dropping below the threshold for 
detection at about 7 wk. 
In the "mixture" group, which received 1.2  X  107 normal cells plus 0.3  X 
107 suppressed cells,  the Ig-lb level at 1 wk reaches 0.18 mg/ml, a value inter- 
mediate between suppressed (0.1) and control (0.38), and then fails in a manner 
similar to the "suppressed control" group, although not quite as sharply. JACOBSON, ltERZENBERG, RIBLET, AND I-IERZENBERG  1169 
Initially, each group consisted of five recipients. However, one animal in the 
suppressed control group and one in the mixture group were excluded because 
the  serum  level  of Ig4b fell  below  detectability,  indicating  rejection  of  the 
spleen cell graft by the irradiated BALB/c recipient. 
There was considerably more variation in the Ig-lb serum levels in the mix- 
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FIG.  1.  Suppression of Ig-Ib production in lethally irradiated Ig  a (BALB/c) recipients of 
a syngeneic mixture of normal and chronically suppressed  (SJL X  BALB/c)F1 spleen cells. 
Recipients irradiated with 600 R  total body irradiation approximately 18 hr before transfer. 
Ig-lb levels determined by inhibition of 125I  precipitation. ]Each point is the geometric average 
of Ig-lb level in four or five recipients. Bars represent :t:sE~i. 
ture group than in either of the control groups, hence the larger standard errors 
of the means for this group. None of the mixture animals, however, aside from 
the first 2 wk after transfer,  ever showed levels of Ig-lb which exceeded one- 
half the level of the lowest normal control,  despite the fact that the mixture 
animals received  1.2  X  107  normal  cells while  the  normal  controls  received 
1.6  X  107 cells from the same suspension. 
Persistence of  Transferred Cells from  Chronically Suppressed F1 (SJL  X 
BALB/c ) in Parental (BALB/c) Recipients.--Using a recipient from the  pre- 
ceding  experiment,  the  persistence of F1 cells after disappearance of the sup- 1170  SUPPRESSION  OF  IMMUNOGLOBULIN  ALLOTYPE  SYNTI-IESIS.  II 
pressed Ig-lb (SJL allotype) marker was demonstrated by a second passage into 
irradiated BALB/c mice. At 12 wk after transfer, a recipient of 1.2 X 107 spleen 
cells from a  chronically suppressed  F1  (suppressed  control group) was  sacri- 
ficed;  107  spleen cells  from this mouse were injected alone into each of five 
irradiated BALB/c mice, and, in combination with 107 normal F1 spleen  cells, 
into  another  five  recipients.  Three  control  mice  each  received  l07  normal 
cells.  As the data in Table V show,  those  animals  receiving  only  passaged 
suppressed cells made low, but clearly measurable, Ig-lb. At 2  wk,  the  levels 
were  approximately equal  to those for the similar time point in the first pas- 
sage. Thus the disappearance of circulating Ig-lb in an original recipient is due 
to suppression of Ig-lb  production rather than to rejection of the  spleen cell 
graft. 
TABLE V 
Survival of Active Suppression through Passage 
Donor cells  No. of 
cells 
No. of  Ig-lb  (weeks) 
recipi- 
ents*  1  2  10 
Normal  10  7 
(SJL  X  BALB/c)Ft spleen 
Suppressed§  spleen  10  z 
(2nd passage) 
Normal  107 
+  + 
suppressed (2nd passage)  107 
mg /ml  mg /ml  mg [ml 
3  0.06  (0.05-0.08):~  0.08  (0.644).73)  0.51  (0.49-0.54 
5  0.02  (0.02-0.02)  0.0Q  f0.07-0.11)  0.07  (0.04-0.15 
5  0.05  ('0.04-0.06)  0.20  (0.18-0.23)  0.11  (0.118-0.15 
* All transfers into  (600 R)  irradiated BALB/c  (Ig-/a) recipients, 
J; Geometric mean (4-s~). 
§ Chronically  suppressed  (SJL  X  BALB/c)Ft  sI,  leen  transferred  into  irradiated  (600 R)  BALB/c  (Ig-la) 
recipient and then, 12 wk later, retransferred into similar recipients. 
Not only does the ability to produce Ig-lb reappear in the second transfer of 
suppressed spleen cells, but along with it is carried the ability to suppress Ig-lb 
production. The inability of the group receiving a mixture of 107 normal  and 
107  suppressed  cells  to produce levels equivalent to  the group  receiving  l07 
normal cells indicates the survival of cells capable of bringing about suppression 
in the second passage. 
As in preceding experiments, graft survival was also verified by measuring 
levels of Ig-4b. As the data in Table VI show, 13 of the 15 irradiated (600 R) 
BALB/c recipients of F1 (SJL X  BALB/c) cells had levels of circulating Ig-4b 
at 7 and 12 wk after transfer comparable to or higher than normal intact Ft 
animals. The remaining two were negative for Ig-4b by 7 wk after transfer, 
indicating rejection of the graft. As stated above, these two animals were ex- 
cluded from the experiment. 
Suppression  of  Ig-Ib  Anti-Sheep  Erythrocyte  Plaque-Forming  Cells.--The JACOBSON~ HERZENBERG~  RIBLE%  AND HERZENBERG  1171 
suppression of Ig-13 production may also be demonstrated in terms of the in- 
ability of  suppressed  cell  populations  to  produce  Ig-lb  antibody  to  SRBC. 
Fig. 2 shows the results obtained after transfer of primed spleen cells from sup- 
pressed and normal mice into irradiated normal  syngeneic recipients. A  chal- 
TABLE VI 
Persistence of Spleen Cell Grafts as Measured by Production of a Nonsuppressed Paternal 
Immunoglob~din 
Ig-4b levels in recipients* 
Cell donor  Recipient No.  (weeks after transfer)  Persistence 
of graft 
1  7  12 
Normal  1  0.58:~  1.3  1.3  -/- 
2  0.39  1.9  1.2  + 
3  0.43  3.2  2.0  + 
4  0.36  1.4  1.1  + 
5  0.54  1.3  N.D.  + 
-Y  0.45§  1.7  1.4 
Suppressed  +  normal  6  0.54  <0.1  <0.1  --[[ 
7  0.77  1.5  2.1  -t- 
8  0.58  2.9  1.9  + 
9  0.51  1.2  0.9  + 
10  0.61  3.2  1.6  + 
)~  0.61  2.0  1.5 
Suppressed  11  0.83  1.2  N.D.  -[- 
12  0.61  <0.1  <0.1  -- 
13  0.96  1.3  2.4  + 
14  0.54  0.8  1.6  q- 
15  0.70  1.5  1.7  + 
.X  0.71  1.2  1.9 
Normal intact F1  _~¶  0.9 
* Ig-4b levels in individual recipients from  mixture experiment described earlier.  Spleen 
cells from  normal (SJL  X  BALB/c)Ft, chronically suppressed (SJL X  BALB/c)F1, and 
3:1 normal:suppressed mixture were transferred into (600 R) irradiated BALB/c recipients. 
N.D., not determined. 
Ig-4b mg/ml serum,  determined by inhibition of 125I precipitation. 
§ Geometric mean. 
[[ Data from animals in which graft did not persist were excluded from all calculations. 
¶ Mean of 18 normal F1 animals of greater than 3 months of age. 
lenge dose of SRBC  was  given at time of transfer.  The  values given are for 
7S-producing  PFC  only.  The  anti-b  allotype  antiserum  used  develops  only 
plaques made by Ig-lb-producing antibody-forming cells (i.e. qtG2~ PFC  of b 
allotype). The  anti-a  allotype serum  used  reacts  with  both  Ig-la  and  Ig-4a 
and therefore develops both 3'G2~ and ~'Gt plaques, which probably accounts 
for the high a/b ratio of PFC in cell suspensions from normal heterozygotes. 1172  SUPPRESSION OF IIv[MUNOGLOBUI,IN  ALLOTYPE  SYNTHESIS. II 
Comparison of suppressed and nonsuppressed  donors  shows that while  the 
recipients of spleen cells from preirmnunized normal donors made both a  and b 
plaques, recipients of spleen cells from prinled suppressed donors made normal 
numbers of a plaques but few or no detectable b plaques (see Fig. 2). 
The appearance of a low number of Ig-lb antibody-forming cells in some of 
the recipients of primed suppressed spleen ceils is consistent with the appearance 
of normal Ig-lb in the sera of recipients of nonimmunized suppressed cells early 
after transfer. The b response seen in these mice probably constitutes a low 7S 
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FIG.  2.  Development of  7S  PFC  in irradiated BALB/c recipients of primed cells from 
(SJL X  BALB/c)F1 (Iga/Ig  b) mice. Donor cells were obtained from normal  (O) or  chronic- 
ally  suppressed  (O)  heterozygotes immunized 4-105  days previously with 4  X  10  s  SRBC. 
A challenge dose of 4 X l0  s SRBC was injected together with the primed cells, and the number 
of antibody-forming cells was determined 7 days later. 
primary response and does not reflect the presence of primed Ig-lb-producing 
cells in suppressed mice. 
Injection o/Suppressed Serum into Normal Mice.--Since suppressed cells were 
capable of carrying over their ability to suppress into secondary hosts, an at- 
tempt was made to "passage suppression" by serum alone. 
Groups of young normal (SJL X  BALB/c)F1 mice, age 3-4 wk, were injected 
intraperitoneally (i.p.) with a serum pool obtained from chronically suppressed 
mice. The mice were injected every 2 days with 0.1-0.3 ml of serum for 3 wk and 
were bled and tested at weekly intervals. Control mice were injected with the 
same amounts of normal BALB/c serum. No reduction in the  level  of  Ig-lb JACOBSON, HERZENBERG, RIBLET~ AND HERZENBERG  1173 
in the recipients of suppressed serum resulted from this regimen; hence if sup- 
pression is mediated by a circulating serum factor, it is either unstable or a more 
subtle means of detecting it must be found. 
DISCUSSION 
The normal process of differentiation to synthesis of 3'G or ~/A immunoglob- 
ulin (or antibody) involves the commitment of an originally totipotent B stem 
cell to the production of a large amount of a unique immunoglobulin molecule. 
During this process, one of the two autosomal chromosomes carrying H-chain 
determinants is selected, the variable region is determined, and one of the four 
linked genes for H-chain constant  regions  (in  the  mouse Ig-1  to Ig-4,  spec- 
ifying "gG2a, ~/A, 3'G~b, and 3'G1, respectively) paired to it in a  manner which 
allows for the transcription of the entire unit as a single messenger. In similar 
fashion a unique light-chain messenger is transcribed. Light and heavy chains are 
then produced, assembled, and exported, while the cell differentiates further to 
a mature plasma cell.  While recent evidence (3, 4)  indicates that during this 
process some or all cells may go through a stage of 3'M production before selec- 
tion of the final 3'G or 3'A class without change in the variable region, this does 
not substantially alter the above description. 
Almost nothing is known of the mechanisms involved in this process. If the 
insertion of a 3'M step proves correct, then chromosome exclusion and variable 
region choice occur earlier than selection of H-chain class. In any event,  at the 
end of the process, a  single cell produces a unique immunoglobulin whose H- 
chain is determined by a gene (or genes) on only one of the two parental chromo- 
somes (5). No other such system for exclusion of autosomal genes is known  in 
mammalian cells. 
In an allotype heterozygote, such chromosomal (or allelic)  exclusion leads  to 
the  presence of  two populations  of immunoglobulin-producing cells for any 
given class,  one making imlnunoglobulins of paternal allotype and the other of 
maternal allotype. Usually an animal has a characteristic ratio of cells producing 
each of the parental allotypes, and circulating immunoglobulins reflect this cel- 
lular ratio (6). While there is little understanding at present of how this ratio 
is maintained, the regularity with which certain allotypes (and classes) predom- 
inate over others suggests that there is more than just random selection oper- 
ating. 
A better understanding of the way in which this normal balance of immuno- 
globulin-producing cells is established may be obtained by studying the mech- 
anism(s)  of allotype suppression,  which  creates a  disruption  of this process, 
leading to a specific decrease both in the number of cells making the suppressed 
allotype (7) and the amount of that allotype found in circulation (8, 7, 1). Un- 
fortunately, such  studies  have been  severely hampered  since  rabbits,  which 
exhibit  long-term  (chronic)  suppression,  are  not  inbred,  while  inbred  mice 
showed only short-term suppression, lasting until 8-10 wk of age (8). The dis- 1174  SUPPRESSION OF  I~MUNOGLOBULIN ALLOTYPE SYNTHESIS. II 
covery of a mouse strain combination, SJLc~  X  BALB/c  9, in which at least 
half  the  progeny of mothers immunized against  a  paternal  allotype become 
phenotypically negative (chronically suppressed) for that allotype at sgme time 
during their life (1) has resolved this problem. 
In  this  publication  we  have  presented  evidence  that  spleen  cells  from 
chronically suppressed mice transferred into irradiated "indicator" hosts show 
an immediate period of production of the paternal (Ig-- lb) allotype, indicating 
clearly that Ig-Ib progenitors are present and capable of differentiating to pro- 
duction in an appropriate environment. Synthesis of the suppressed allotype 
terminates, however, within 1-3 wk, even though transferred cells (as demon- 
strated  by other markers)  survive indefinitely and spleen cells from  normal 
animals transferred into identical hosts continue to produce Ig-ib.  Thus, either 
the  cells  are  intrinsically  unable  to  sustain  Ig-lb  production  or  another 
cell type in the transferred suppressed spleen population prevents Ig-lb produc- 
tion after a short period. The latter possibility was the most likely, in view  of 
the inability of normal spleen cells to sustain Ig-lb production in  suppressed 
hosts (1). This possibility was tested more directly by transferring a mixture of 
syngeneic spleen cells from suppressed and normal animals. As in the case of 
transfer of suppressed spleen cells alone, Ig-lb production by the mixture of 
cells  occurred immediately  after  transfer  and  decreased  rapidly  (or  ceased) 
shortly thereafter. In  subsequent  experiments (not presented here)  we  have 
found that the amount of Ig-lb produced depends in part on the ratio of sup- 
pressed spleen cells to normal spleen cells3 
Thus spleens of suppressed animals not only contain a population of progen- 
itors of Ig-lb-produeing cells but also contain a population of cells capable of 
preventing these progenitors from expressing their potentiality. Whether the 
suppressors act by direct cell-to-cell interaction, or produce a factor which con- 
ditions the environment, is as yet unclear. While the lag in expression of suppres- 
sion might indicate the latter, as yet it has not been possible to suppress [g-lb 
production by transfer of large amounts of serum from suppressed animals. In 
any event, since injection of large amounts of Ig  b serum before cell transfer does 
not relieve suppression, we can be fairly certain that if a serum factor is being 
produced, it is not simply antibody to Ig-lb as it appears on circulating globu- 
lins. This does not rule out the existence of an antigen unique to the progenitors 
of Ig-lb-producing cells,  e.g.  cell-bound Ig-lb  with  a  different configuration, 
which identifies the progenitors for the suppressor. 
The fact that retransfer of suppressed spleen cells alone and in mixtures with 
normal spleen cells leads to a repeat of the transfer sequence, i.e. Ig-lb produc- 
tion and subsequent termination, suggests strongly that the suppressing  cells 
are able to proliferate and that the effectors of suppression seen in the recipients 
are similar to those in the original suppressed animals. The specificity of the sup- 
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pressor population for Ig-lb-producing cells reflects the specificity of the original 
maternal antibody, which we have shown to react detectably only with Ig-lb. 
From the data available thus far it is not possible to determine whether the 
transferred Ig-lb progenitor cells have already passed through the allelic exclu- 
sion stage, no less whether they are already committed to Ig-lb production and 
await  only the  trigger to  begin  differentiation toward  actively synthesizing 
plasma cells. It is possible that the suppressor cell exerts a static action on cells 
just before the final differentiational pathway,  but equally possible that  the 
suppressor destroys or diverts any cell which becomes committed to production 
of the suppressed allotype. We can state only that along the normal pathway 
from unconlmitted progenitor to Ig-lb producer, the cell passes through a stage 
where it is identifiable as committed or able to be committed to Ig-lb produc- 
tion, and that the suppressor (cell or factor) can recognize the cell at this stage 
and prevent it from continuing its progression to synthesis of Ig-lb. 
The nature and mode of action of the suppressor also remains to be elucidated. 
Preliminary experiments indicate that it is  a  thymus-derived (0-bearing)  cell 
present in reasonable numbers in thymus as well as in spleen from 6-month-old 
suppressed mice. ~ As mentioned earlier, this cell appears to be capable of pro- 
liferation. How it arises as a consequence of exposure of the young animal to 
anti-allotype antibody,  and  whether it has  a  normal  counterpart which,  for 
example, regulates the level of Ig-13 in serum, has yet to be determined. 
Preliminary evidence suggests that chronic allotype suppression in mice can 
be induced only when SJL mice are used as one of the parent strains. Since SJL 
mice are known to suffer from severe fluctuating disgammaglobulinemias  (9) 
and  to ultimately die of reticulum cell sarcoma  (10),  it  is  possible  that  the 
heterozygote has  a  faulty immunoglobulin  regulation  system  as  well,  which 
reacts to perturbation by the initial maternal Ig-lb by producing an overactive 
Ig-lb regulating mechanism. 
SUMMARY 
The mechanism of chronic  allotype  suppression  in (SJL X  BALB/c)FI  mice 
has been investigated  by means of cell  transfer  studies. 
These mice are  phenotypically negative  for  serum Ig-lb,  the  patelnal  allotype 
determinant on "~,G2~  immunoglubulin,  as a result of perinatal exposure  to 
maternal anti-Ig-lb. 
When spleen or bone marrow (B) cells from suppressed mice weie injected 
into irradiated BALB/c "indicator" hosts, detectable levels of Ig-lb were dem- 
onstrated in the sera of a majority of the recipients early after transfer. These 
results indicate that Ig-lb-producing cells or their precursors are present in the 
lymphoid tissues of suppressed mice, even though they are not expressed. 
Within 5-7 wk, it was no longer possible to detect Ig-13 in the sera of these 
hosts,  although cells producing another paternal allotype (Ig-4b) were shown 
to persist. Control BALB/c mice, injected with spleen and B cells from nolmal 
mice, continued to produce high levels of immunoglobulin carrying this allotype. 1176  SUPPRESSION  OF IMMUNOGLOBULIN  ALLOTYPE  SYNTHESIS. II 
The disappearance of serum Ig-lb occurred most frequently in the recipients of 
suppressed spleen cells. 
Similar results were obtained using a mixture of spleen cells from normal and 
suppressed  mice.  Ig-Ib  production  in  the  recipient  mice  ceased within  a  few 
weeks,  even  though the  majority  of cells  in  the  mixture  were  obtained from 
normal (nonsuppressed)  donors. 
The  data  are  interpreted  as  evidence  that  chronic  allotype suppression  in 
mice is actively maintained by cells which  are resident in the lymphoid tissues, 
splenic cells being the most effective. These cells are  capable of proliferating in 
a  new host  and  exerting  their  suppressive  influence  on Ig-lb-producing cells 
and/or their precursors. 
The authors  with to express their gratitude  to F. T. Gadus, M. Ravitch,  and D. Hewgill 
for excellent technical assistance. 
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